Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.

Published

Journal Article

OBJECTIVE: To examine US physicians' self-reported knowledge about the Polypill, factors considered in deciding whether to prescribe it, and acceptance of prescribing it for cardiovascular disease (CVD) prevention. METHODS: Numerical scales of 0 (lowest) to 5 (highest) were used to assess self-reported knowledge and importance of factors relevant to making a decision to prescribe a Polypill. Characteristics of physicians indicating they would prescribe a Polypill were compared. RESULTS: Among 952 physicians surveyed February through March 2010, mean self-rated knowledge about the Polypill was 2.0±1.5. Importance of degree of CVD event reduction, cost, and side effects were rated with means of 4.4, 4.3, and 4.3, respectively. 83% of respondents indicated they would "definitely" or "probably" prescribe it for high-risk patients; 62% would do so for moderate risk patients. Physicians with self-rated knowledge at ≥75th percentile were more likely to indicate they would prescribe a Polypill for moderate risk (adjusted OR 2.16; 95% CI 1.60-2.93) and high-risk (adjusted OR 1.57; 95% CI 1.07-2.32) patients. CONCLUSION: Among this sample of physicians, there is relatively high acceptance of prescribing a Polypill for CVD prevention despite relatively modest knowledge about it.

Full Text

Duke Authors

Cited Authors

  • Viera, AJ; Sheridan, SL; Edwards, T; Soliman, EZ; Harris, R; Furberg, CD

Published Date

  • January 2011

Published In

Volume / Issue

  • 52 / 1

Start / End Page

  • 10 - 15

PubMed ID

  • 20933538

Pubmed Central ID

  • 20933538

Electronic International Standard Serial Number (EISSN)

  • 1096-0260

Digital Object Identifier (DOI)

  • 10.1016/j.ypmed.2010.09.016

Language

  • eng

Conference Location

  • United States